![Raphaël Durand](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Raphaël Durand
Directeur/Membre du Conseil chez Axilum Robotics SAS
Postes actifs de Raphaël Durand
Sociétés | Poste | Début | Fin |
---|---|---|---|
Axilum Robotics SAS
![]() Axilum Robotics SAS Miscellaneous Commercial ServicesCommercial Services Axilum Robotics SAS develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures. Its first project is a robot to assist psychiatrists and neurologists for Transcranial Magnetic Stimulation (TMS). The firm's project TMS is a painless, non invasive medical technique that applies high intensity magnetic impulses to cortex areas by placing a coil on the surface of the head. The company was founded by Bernard Bayle, Michel Berg, Michel de Mathelin, Romuald Ginhoux, Benjamin Maurin and Pierre Renaud in April 2011 and is headquartered in Strasbourg, France. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Raphaël Durand
Anciens postes connus de Raphaël Durand
Sociétés | Poste | Début | Fin |
---|---|---|---|
Echosens North America, Inc.
![]() Echosens North America, Inc. Medical DistributorsDistribution Services Part of Inner Mongolia Furui Medical Science Co., Ltd., Echosens North America, Inc. is a company that manufactures FibroScan®, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease. The company is based in Waltham, MA. The company's agile 4 (FibroScan®-based score) is a test for the identification of cirrhosis in NAFLD patients combining LSM by VCTE™ with blood biomarkers (AST, ALT, platelets). The company is shaping the future of liver health and empowering medical professionals to manage liver health for simpler, faster, and better patient care. Jon S. Gingrich has been the CEO of the company since 2019. | Directeur Général | 01/01/2015 | 27/08/2019 |
Echosens SA
![]() Echosens SA Medical SpecialtiesHealth Technology Echosens SA engages in the manufacture of medical imaging equipment. It focuses on developing FibroScan. The company was founded by Laurent Sandrin and Sylvain Yon on June 20, 2001 and is headquartered in Paris, France. | Directeur Financier/CFO | 03/02/2014 | 01/01/2019 |
Secrétaire Général | 03/02/2014 | 01/01/2019 | |
EUROPACORP | Directeur Administratif | 01/03/2003 | 01/04/2011 |
EUROPACORP | Directeur Financier/CFO | 20/07/2010 | - |
Public Communications Contact | 22/12/2010 | - |
Formation de Raphaël Durand
ESSEC Business School | Undergraduate Degree |
Statistiques
Internationale
France | 5 |
Etats-Unis | 2 |
Opérationnelle
Director of Finance/CFO | 2 |
Public Communications Contact | 1 |
Undergraduate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
EUROPACORP | Consumer Services |
Entreprise privées | 3 |
---|---|
Echosens SA
![]() Echosens SA Medical SpecialtiesHealth Technology Echosens SA engages in the manufacture of medical imaging equipment. It focuses on developing FibroScan. The company was founded by Laurent Sandrin and Sylvain Yon on June 20, 2001 and is headquartered in Paris, France. | Health Technology |
Echosens North America, Inc.
![]() Echosens North America, Inc. Medical DistributorsDistribution Services Part of Inner Mongolia Furui Medical Science Co., Ltd., Echosens North America, Inc. is a company that manufactures FibroScan®, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease. The company is based in Waltham, MA. The company's agile 4 (FibroScan®-based score) is a test for the identification of cirrhosis in NAFLD patients combining LSM by VCTE™ with blood biomarkers (AST, ALT, platelets). The company is shaping the future of liver health and empowering medical professionals to manage liver health for simpler, faster, and better patient care. Jon S. Gingrich has been the CEO of the company since 2019. | Distribution Services |
Axilum Robotics SAS
![]() Axilum Robotics SAS Miscellaneous Commercial ServicesCommercial Services Axilum Robotics SAS develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures. Its first project is a robot to assist psychiatrists and neurologists for Transcranial Magnetic Stimulation (TMS). The firm's project TMS is a painless, non invasive medical technique that applies high intensity magnetic impulses to cortex areas by placing a coil on the surface of the head. The company was founded by Bernard Bayle, Michel Berg, Michel de Mathelin, Romuald Ginhoux, Benjamin Maurin and Pierre Renaud in April 2011 and is headquartered in Strasbourg, France. | Commercial Services |
- Bourse
- Insiders
- Raphaël Durand
- Expérience